A humanized anti-Toll like receptor 4 antibody Fab fragment inhibits pro-inflammatory responses induced by lipopolysaccharide through TLR4 in vitro and in vivo
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.20194 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Wenkai Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Diseases of Qinhuai Medical District, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Lipopolysaccharides, Immunoglobulin Fab Fragments, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Toll like receptor 4 (TLR4) and its co-receptor MD-2 recognize bacterial lipopolysaccharide (LPS), initiating responses to infections caused by Gram-negative bacteria. TLR4 also plays a role in various pathological processes, including viral infections and sterile inflammation. However, effective methods to inhibit LPS/TLR4-mediated inflammation remain elusive. This study aimed to evaluate the inhibitory effects of a constructed hTLR4-Fab on LPS-induced inflammation in both in vitro and in vivo settings. Methodology: In vitro, mouse dendritic cells (DCs), human macrophages, and human DCs were incubated with hTLR4-Fab and then stimulated with LPS. In vivo, mice were pre-treated with a humanized anti-TLR4 antibody Fab prior to LPS injection. We examined the activation of various signaling pathways to elucidate the molecular mechanism underlying the inhibition of LPS-induced inflammation by hTLR4-Fab.
Results
We observed that the binding affinity of hTLR4-Fab to TLR4 on mouse bone marrow-derived dendritic cells (DCs) was approximately 81.8%, while the binding affinity to human blood monocyte-derived macrophages and DCs exceeded 90%. Pretreatment with hTLR4-Fab significantly reduced both mRNA and protein levels of LPS-induced proinflammatory cytokines. In vivo, a significant suppression of serum cytokine expression was driven by hTLR4-Fab treatment.
Conclusions
The results demonstrated that the antibody Fab could impede the phosphorylation of downstream components, including the nuclear factor κB (NF-κB) signaling pathway, the mitogen-activated protein kinase (MAPK) signaling pathway, and IFN regulatory factor 3 (IRF-3), all of which are activated by TLR4. Consequently, our study demonstrates that our hTLR4-Fab is effective in mitigating LPS-induced inflammation, both in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Diseases of Qinhuai Medical District, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
- Department of Gastroenterology, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China.
- Research Institute for Medicine of Nanjing Command, Nanjing, Jiangsu, China.
- Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University; The First People's Hospital of Yancheng, Yancheng, Jiangsu, China.
Zitieren
APA
Zheng, W., Xie, F., Si, S., Xiong, X., Xu, J., Yao, C., Li, C., Zhu, J., Li, P., Cai, B., & Wang, M. (2025). A humanized anti-Toll like receptor 4 antibody Fab fragment inhibits pro-inflammatory responses induced by lipopolysaccharide through TLR4 in vitro and in vivo. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20194
Vancouver
Zheng W, Xie F, Si S, Xiong X, Xu J, Yao C, et al. A humanized anti-Toll like receptor 4 antibody Fab fragment inhibits pro-inflammatory responses induced by lipopolysaccharide through TLR4 in vitro and in vivo. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20194
BibTeX
@article{Zheng2025,
author = {Zheng, Wenkai and Xie, Fang and Si, Shuping and Xiong, Xi and Xu, Jing and Yao, Chuanxia and Li, Cong and Zhu, Jin and Li, Ping and Cai, Binggang and Wang, Maorong},
title = {A humanized anti-Toll like receptor 4 antibody Fab fragment inhibits pro-inflammatory responses induced by lipopolysaccharide through TLR4 in vitro and in vivo},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.20194}
}
EUVIMED